Anterior Shoulder Instability Treated With a Semitendinosus Subscapular Sling Procedure

Sponsor
Helse Møre og Romsdal HF (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03424421
Collaborator
Norwegian University of Science and Technology (Other), Oslo University Hospital (Other)
15
1
1
64.3
0.2

Study Details

Study Description

Brief Summary

The arthroscopic subscapular sling procedure is a new technique for shoulder stabilization, which has been developed in human cadaveric studies by Klungsøyr et al, but has yet to be tested clinically. The procedure stabilizes the shoulder by using a semitendinosus graft that makes a new labrum and a sling around the subscapular tendon. Extensive biomechanical robotic testing of the procedure shows significant less translation and thus better stability of the humeral head with the sling compared to a normal Bankart repair. The investigators consider the biomechanical results after robotic testing sufficient to advocate a planned pilot study in humans. In this pilot study the clinical and radiological results of the sling will be investigated in a small number of cases. The safety of the subscapular sling procedure will be assessed. This studies results are expected to be a further step towards implementation of the sling procedure as a surgical option for shoulder instability.

Condition or Disease Intervention/Treatment Phase
  • Procedure: subscapular sling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
pilot studypilot study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Anterior Shoulder Instability Treated With a Semitendinosus Subscapular Sling Procedure. Pilot Study, a New Surgical Procedure
Actual Study Start Date :
Dec 20, 2017
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: subscapular sling

semitendinosus subscapular sling procedure

Procedure: subscapular sling
semitendinosus subscapular sling procedure

Outcome Measures

Primary Outcome Measures

  1. The recurrence rate of shoulder dislocation after the subscapular sling [2 years follow up.]

    Explore to what extent the subscapular sling procedure is successful in preventing recurrent shoulder dislocations

Secondary Outcome Measures

  1. Changes in the Western Ontario Shoulder Instability index (WOSI) score [2 years follow up.]

    Changes in the WOSI score, comparing results preoperatively

  2. Changes in the range of motions [2 years follow up.]

    Range of motions, comparing postoperative results with preoperative measurements in the operated shoulder

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical anterior instability of the shoulder and/or previous failed Bankart repair or arthroscopic findings concluding with too weak anterior structures to perform capsulolabral or labrum repair

  • Be able to understand oral and written Norwegian /English

Exclusion Criteria:
  • Cuff injury or previous cuff repair

  • Surgical fracture treatment of the glenoid or humeral head

  • Other instability procedures in the shoulder except Bankart repair and anterior capsular plications

  • Previous infections in the shoulder

  • MRI detectable fatty infiltration of the subscapularis or partial/total tendon rupture

  • Severe glenohumeral arthrosis

  • Multidirectional or posterior instability

  • Not able to comply fully with the protocol due to psychosocial and physical conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalesund Hospital Møre and Romsdal Hospital Trust Ålesund Norway 6013

Sponsors and Collaborators

  • Helse Møre og Romsdal HF
  • Norwegian University of Science and Technology
  • Oslo University Hospital

Investigators

  • Study Director: Jon Olav Drogset, MD PhD prof, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Helse Møre og Romsdal HF
ClinicalTrials.gov Identifier:
NCT03424421
Other Study ID Numbers:
  • 2017/1292
First Posted:
Feb 7, 2018
Last Update Posted:
Mar 16, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Helse Møre og Romsdal HF
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2022